Correlation Between Opthea and MediciNova
Can any of the company-specific risk be diversified away by investing in both Opthea and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and MediciNova, you can compare the effects of market volatilities on Opthea and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and MediciNova.
Diversification Opportunities for Opthea and MediciNova
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Opthea and MediciNova is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Opthea i.e., Opthea and MediciNova go up and down completely randomly.
Pair Corralation between Opthea and MediciNova
Considering the 90-day investment horizon Opthea is expected to generate 1.33 times less return on investment than MediciNova. But when comparing it to its historical volatility, Opthea is 1.78 times less risky than MediciNova. It trades about 0.1 of its potential returns per unit of risk. MediciNova is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 165.00 in MediciNova on September 3, 2024 and sell it today you would earn a total of 42.00 from holding MediciNova or generate 25.45% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Opthea vs. MediciNova
Performance |
Timeline |
Opthea |
MediciNova |
Opthea and MediciNova Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Opthea and MediciNova
The main advantage of trading using opposite Opthea and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
MediciNova vs. DiaMedica Therapeutics | MediciNova vs. Lyra Therapeutics | MediciNova vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements |